Trinity Biotech plc (NASDAQ:TRIB) — Market Cap & Net Worth
Market Cap & Net Worth: Trinity Biotech plc (TRIB)
Trinity Biotech plc (NASDAQ:TRIB) has a market capitalization of $5.72 Million ($5.72 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28424 globally and #5829 in its home market, demonstrating a -22.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trinity Biotech plc's stock price $7.03 by its total outstanding shares 813132 (813.13K). Also see balance sheet size of Trinity Biotech plc for a full breakdown of the balance sheet.
Trinity Biotech plc Market Cap History: 2015 to 2026
Trinity Biotech plc's market capitalization history from 2015 to 2026. Data shows change from $47.81 Million to $5.72 Million (-17.81% CAGR). Also see cash efficiency ratio of Trinity Biotech plc for how efficiently the company converts equity into cash flow.
Index Memberships
Trinity Biotech plc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #821 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2631 of 3165 |
Weight: Trinity Biotech plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Trinity Biotech plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trinity Biotech plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Trinity Biotech plc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.01x
Trinity Biotech plc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.13 Million | $99.61 Million | -$100.63 Million | 0.28x | N/A |
| 2017 | $20.73 Million | $99.14 Million | -$40.27 Million | 0.21x | N/A |
| 2018 | $9.31 Million | $97.03 Million | $2.39 Million | 0.10x | 3.90x |
| 2019 | $4.20 Million | $90.44 Million | -$4.07 Million | 0.05x | N/A |
| 2020 | $15.49 Million | $101.98 Million | -$6.39 Million | 0.15x | N/A |
| 2021 | $5.81 Million | $81.15 Million | $875.00K | 0.07x | 6.64x |
| 2022 | $4.03 Million | $62.52 Million | -$41.00 Million | 0.06x | N/A |
| 2023 | $1.74 Million | $56.83 Million | -$24.02 Million | 0.03x | N/A |
| 2024 | $715.72K | $61.55 Million | -$31.79 Million | 0.01x | N/A |
| 2025 | $643.19K | $43.78 Million | -$37.38 Million | 0.01x | N/A |
Competitor Companies of TRIB by Market Capitalization
Companies near Trinity Biotech plc in the global market cap rankings as of September 18, 2026. Review TRIB goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Trinity Biotech plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Trinity Biotech plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Trinity Biotech plc's market cap moved from $47.81 Million to $ 5.72 Million, with a yearly change of -17.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.72 Million | +788.75% |
| 2025 | $643.19K | -10.13% |
| 2024 | $715.72K | -58.97% |
| 2023 | $1.74 Million | -56.67% |
| 2022 | $4.03 Million | -30.77% |
| 2021 | $5.81 Million | -62.47% |
| 2020 | $15.49 Million | +268.69% |
| 2019 | $4.20 Million | -54.87% |
| 2018 | $9.31 Million | -55.10% |
| 2017 | $20.73 Million | -26.30% |
| 2016 | $28.13 Million | -41.16% |
| 2015 | $47.81 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Trinity Biotech plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.72 Million USD |
| MoneyControl | $5.72 Million USD |
| MarketWatch | $5.72 Million USD |
| marketcap.company | $5.72 Million USD |
| Reuters | $5.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Trinity Biotech plc
Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually tr… Read more